FDA 483 - Dante Pieramici, M.D. - February 10, 2023

Dante Pieramici, M.D., a clinical investigator in Santa Barbara, CA, was cited for failing to conduct an investigation in accordance with the investigational plan. The primary issue involved multiple temperature excursions for investigational product storage, affecting numerous subjects. This represents a significant deviation from protocol requirements.